Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Kyu-Won Kim"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Special Article
How Can We Treat Cancer Disease Not Cancer Cells?
Kyu-Won Kim, Su-Jae Lee, Woo-Young Kim, Ji Hae Seo, Ho-Young Lee
Cancer Res Treat. 2017;49(1):1-9.   Published online December 26, 2016
DOI: https://doi.org/10.4143/crt.2016.606
AbstractAbstract PDFPubReaderePub
Since molecular biology studies began, researches in biological science have centered on proteins and genes at molecular level of a single cell. Cancer research has also focused on various functions of proteins and genes that distinguish cancer cells from normal cells. Accordingly, most contemporary anticancer drugs have been developed to target abnormal characteristics of cancer cells. Despite the great advances in the development of anticancer drugs, vast majority of patients with advanced cancer have shown grim prognosis and high rate of relapse. To resolve this problem, we must reevaluate our focuses in current cancer research. Cancer should be considered as a systemic disease because cancer cells undergo a complex interaction with various surrounding cells in cancer tissue and spread to whole body through metastasis under the control of the systemic modulation. Human body relies on the cooperative interaction between various tissues and organs, and each organ performs its specialized function through tissue-specific cell networks. Therefore, investigation of the tumor-specific cell networks can provide novel strategy to overcome the limitation of current cancer research. This review presents the limitations of the current cancer research, emphasizing the necessity of studying tissue-specific cell network which could be a new perspective on treating cancer disease, not cancer cells.

Citations

Citations to this article as recorded by  
  • New Breakthroughs in the Diagnosis of Leptomeningeal Carcinomatosis: A Review of Liquid Biopsies of Cerebrospinal Fluid
    Maria Goldberg, Michel G Mondragon-Soto, Ghaith Altawalbeh, Bernhard Meyer, Amir Kaywan Aftahy
    Cureus.2024;[Epub]     CrossRef
  • Equine Melanocytic Tumors: A Narrative Review
    José Pimenta, Justina Prada, Mário Cotovio
    Animals.2023; 13(2): 247.     CrossRef
  • Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation
    Ion G. Motofei
    Seminars in Cancer Biology.2022; 86: 600.     CrossRef
  • Mechanisms of resistance to chemotherapy in non-small cell lung cancer
    Hye-Young Min, Ho-Young Lee
    Archives of Pharmacal Research.2021; 44(2): 146.     CrossRef
  • The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma Patients
    Giovanni Paolino, Veronica Huber, Serena Camerini, Marialuisa Casella, Alberto Macone, Lucia Bertuccini, Francesca Iosi, Elisa Moliterni, Serena Cecchetti, Irene Ruspantini, Flavia Chiarotti, Elisabetta Vergani, Luca Lalli, Carla Raggi, Antonella Di Biase
    Cancers.2021; 13(16): 4157.     CrossRef
  • Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer
    Ya-Ling Hsu, Ming-Shyan Huang, Jen-Yu Hung, Wei-An Chang, Ying-Ming Tsai, Yi-Chung Pan, Yi-Shiuan Lin, Hung-Pei Tsai, Po-Lin Kuo
    Oncogene.2020; 39(4): 739.     CrossRef
  • 18,687 View
  • 336 Download
  • 6 Web of Science
  • 6 Crossref
Close layer
Review Article
HIF-1α: a Valid Therapeutic Target for Tumor Therapy
Soon-Sun Hong, Hyunseung Lee, Kyu-Won Kim
Cancer Res Treat. 2004;36(6):343-353.   Published online December 31, 2004
DOI: https://doi.org/10.4143/crt.2004.36.6.343
AbstractAbstract PDFPubReaderePub

Hypoxia plays a major role in the induction of angiogenesis during tumor development. One mechanism by which tumor cells respond to a reduced oxygen level is via the activation of hypoxia-inducible factor-1 (HIF-1). HIF-1 is an oxygen-dependent transcriptional activator that plays crucial roles in the angiogenesis of tumors and mammalian development. HIF-1 consists of a constitutively expressed HIF-1β subunit and the highly regulated HIF-1α subunits. The stability and activity of HIF-1α are regulated by various post-translational modifications, hydroxylation, acetylation, phosphorylation and sumoyaltion. Therefore, HIF-1α interacts with several protein factors including PHD, pVHL, ARD-1, SUMO and p300/CBP. Under normoxia, the HIF-1α subunit is rapidly degraded via the von Hippel-Lindau tumor suppressor gene product (pVHL)-mediated ubiquitin/proteasome pathway. The association of pVHL and HIF-1α under normoxic conditions is triggered by the hydroxylation of prolines and the acetylation of lysine within a polypeptide segment known as the oxygen-dependent degradation (ODD) domain. On the contrary, under the hypoxia condition, the HIF-1α subunit becomes stable and interacts with coactivators such as p300/CBP to modulate its transcriptional activity. Under hypoxic conditions, HIF-1 eventually acts as a master regulator of numerous hypoxia-inducible genes. The target genes of HIF-1 are especially related to angiogenesis, cell proliferation and survival, and to glucose and iron metabolism. Moreover, it was reported that the activation of HIF-1α is closely associated with a variety of tumors and oncogenic pathways. Hence, the blocking of HIF-1α itself or the blocking of HIF-1α interacting proteins inhibits tumor growth. Based on these findings, HIF-1 can be a prime target for anticancer therapies. Therefore, this review summarizes the molecular mechanism of HIF-1α stability, the biological functions of HIF-1 and its potential applications for cancer therapies.

Citations

Citations to this article as recorded by  
  • A comprehensive review on therapeutic potentials of photobiomodulation for neurodegenerative disorders
    Pooja Ramakrishnan, Aradhana Joshi, Mohamed Fazil, Pankaj Yadav
    Life Sciences.2024; 336: 122334.     CrossRef
  • Novel Benzochromenes: Design, Synthesis, Cytotoxicity, Molecular Docking and Mechanistic Investigations
    Fatma G Abdulrahman, Hamada S Abulkhair, Riham A Zidan, Asmaa I Alwakeel, Ahmed A Al-Karmalawy, Ebtehal M Husseiny
    Future Medicinal Chemistry.2024; 16(2): 105.     CrossRef
  • Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application
    Liang Zhao, Junchen Guo, Shasha Xu, Meiqi Duan, Baiming Liu, He Zhao, Yihan Wang, Haiyang liu, Zhi Yang, Hexue Yuan, Xiaodi Jiang, Xiaofeng Jiang
    Journal of Advanced Research.2024;[Epub]     CrossRef
  • Role of natural secondary metabolites as HIF-1 inhibitors in cancer therapy
    Prem Shankar Mishra, Rakhi Mishra, Vaishali Manikrao Patil, Samiksha Dewangan
    Medicinal Chemistry Research.2024; 33(5): 721.     CrossRef
  • SIMULATED AEROMEDICAL EVACUATION EXACERBATES ACUTE LUNG INJURY VIA HYPOXIA-INDUCIBLE FACTOR-1α-MEDIATED BNIP3/NIX-DEPENDENT MITOPHAGY
    Chunli Yin, Xinyang Liu, Yujie Ma, Zibo Tang, Wenmin Guo, Bingbing Sun, Jingmei He
    Shock.2024;[Epub]     CrossRef
  • Inferring upstream regulatory genes of FOXP3 in human regulatory T cells from time-series transcriptomic data
    Stefano Magni, Rucha Sawlekar, Christophe M. Capelle, Vera Tslaf, Alexandre Baron, Ni Zeng, Laurent Mombaerts, Zuogong Yue, Ye Yuan, Feng Q. Hefeng, Jorge Gonçalves
    npj Systems Biology and Applications.2024;[Epub]     CrossRef
  • Stilbenoid derivatives as potent inhibitors of HIF-1α-centric cancer metabolism under hypoxia
    Tae-Hee Han, Joohan Lee, Dipesh S. Harmalkar, Hyeseul Kang, Guanghai Jin, Min Kyung Park, Minkyoung Kim, Hyun-A Yang, Jinsu Kim, Su Jeong Kwon, Tae-Su Han, Yongseok Choi, Misun Won, Hyun Seung Ban, Kyeong Lee
    Biomedicine & Pharmacotherapy.2024; 176: 116838.     CrossRef
  • Targeting Hypoxia and HIF1α in Triple-Negative Breast Cancer: New Insights from Gene Expression Profiling and Implications for Therapy
    Delong Han, Zeyu Li, Lingjie Luo, Hezhong Jiang
    Biology.2024; 13(8): 577.     CrossRef
  • The Effects of Normobaric Hypoxia on the Acute Physiological Responses to Resistance Training: A Narrative Review
    Giselle L. Allsopp, Florian A. Britto, Craig R. Wright, Louise Deldicque
    Journal of Strength & Conditioning Research.2024;[Epub]     CrossRef
  • Physiological hypoxia promotes cancer cell migration and attenuates angiogenesis in co-culture using a microfluidic device
    Satoshi Aratake, Kenichi Funamoto
    Microfluidics and Nanofluidics.2024;[Epub]     CrossRef
  • Design, synthesis, molecular dynamics and gene silencing studies of novel therapeutic HIF-1α siRNAs in hypoxic cancer cells
    Jyoti Singh, Sneha Yadav, Archana Bharti Sonkar, Anurag Kumar, Neeraj Kumar Shrivastava, Rohit Kumar, Dharmendra Kumar, Mohd Nazam Ansari, Abdulaziz S. Saeedan, Gaurav Kaithwas
    International Journal of Biological Macromolecules.2024; 282: 136943.     CrossRef
  • Concise Asymmetric Total Syntheses of (+)-Dihydropleurotinic Acid and (−)-Pleurotin, Enabling Rapid Late-Stage Diversification
    Bin Huang, Jing Pang, Nan Cao, Ya-Shuang Dai, Ya-Qiu Long
    JACS Au.2024; 4(11): 4206.     CrossRef
  • Targeting HIF-1 for prostate cancer: a synthesis of preclinical evidence
    Yarden Zohar, Nicola J. Mabjeesh
    Expert Opinion on Therapeutic Targets.2023; 27(8): 715.     CrossRef
  • Transcriptome Analysis on Hepatopancreas Reveals the Metabolic Dysregulation Caused by Vibrio parahaemolyticus Infection in Litopenaeus vannamei
    Miao Miao, Shihao Li, Yuan Liu, Yang Yu, Fuhua Li
    Biology.2023; 12(3): 417.     CrossRef
  • Determination of HIF-1α degradation pathways via modulation of the propionyl mark
    Kwanyoung Jeong, Jinmi Choi, Ahrum Choi, Joohee Shim, Young Ah Kim, Changseok Oh, Hong-Duk Youn, Eun-Jung Cho
    BMB Reports.2023; 56(4): 252.     CrossRef
  • Baf155 regulates skeletal muscle metabolism via HIF-1a signaling
    Jong-Seol Kang, Dongha Kim, Joonwoo Rhee, Ji-Yun Seo, Inkuk Park, Ji-Hoon Kim, Daewon Lee, WonUk Lee, Ye Lynne Kim, Kyusang Yoo, Sunghwan Bae, Jongkyeong Chung, Rho Hyun Seong, Young-Yun Kong, Simon M. Hughes
    PLOS Biology.2023; 21(7): e3002192.     CrossRef
  • Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease
    Christopher Bailey, Yuanyi Wei, Jinsong Yan, Dan Huang, Peng Zhang, Chong Qi, Christopher Lazarski, JuanJuan Su, Fei Tang, Chun-shu Wong, Pan Zheng, Yan Liu, Yang Liu, Yin Wang
    Cell Reports Medicine.2023; 4(11): 101236.     CrossRef
  • Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies
    Jade Fantin, Jérôme Toutain, Elodie A. Pérès, Benoit Bernay, Sarina Maya Mehani, Charly Helaine, Mickael Bourgeois, Carole Brunaud, Laurent Chazalviel, Julien Pontin, Aurélien Corroyer-Dulmont, Samuel Valable, Michel Cherel, Myriam Bernaudin
    EJNMMI Research.2023;[Epub]     CrossRef
  • Exploring mRNA Translation Strategies for Hypoxia Adaptation Across Distantly Related Metazoans
    Manfei Liang, Qingyou Zhao, Yixiang Song, Jianchao Chen
    Epigenomics.2023; 15(20): 1069.     CrossRef
  • Novel thioether linked 4-hydroxycoumarin derivatives: Synthesis, characterization, in vitro pharmacological investigation and molecular docking studies
    B. Manjunatha, Yadav D. Bodke, H.M. Kumaraswamy, P. Meghana, O. Nagaraja, G.C. Anjan kumar
    Journal of Molecular Structure.2022; 1249: 131642.     CrossRef
  • A Concise Synthesis of Pleurotin Enabled by a Nontraditional C–H Epimerization
    John F. Hoskin, Erik J. Sorensen
    Journal of the American Chemical Society.2022; 144(31): 14042.     CrossRef
  • Regulatory mechanisms and function of hypoxia-induced long noncoding RNA NDRG1-OT1 in breast cancer cells
    Hsing-Hua Chao, Jun-Liang Luo, Ming-Hsuan Hsu, Li-Han Chen, Tzu-Pin Lu, Mong-Hsun Tsai, Eric Y. Chuang, Li-Ling Chuang, Liang-Chuan Lai
    Cell Death & Disease.2022;[Epub]     CrossRef
  • A dynamic fluorescence probed glycolysis suppression process in HeLa cells treated with trichostatin A
    Fengqiu Zhang, Changsheng Shao, Yahui Wu, Wei Zhao, Xumiao Jing, Cao Fang, Qing Huang
    The Analyst.2022; 147(22): 5082.     CrossRef
  • Polystyrene-Based Slippery Surfaces Enable the Generation and Easy Retrieval of Tumor Spheroids
    Priyanka Pulugu, Neha Arya, Prasoon Kumar, Akshay Srivastava
    ACS Applied Bio Materials.2022; 5(12): 5582.     CrossRef
  • Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination
    Shereen El Shorbagy, Fouad abuTaleb, Hany A. Labib, Huda Ebian, Ola A. Harb, Mona Saeed Mohammed, Hanaa A. Rashied, Khaled A. Elbana, Rasha Haggag
    Journal of Gastrointestinal Cancer.2021; 52(1): 269.     CrossRef
  • Adenylate Kinase 4 Promotes Inflammatory Gene Expression via Hif1α and AMPK in Macrophages
    Wei-Yao Chin, Chi-Ying He, Tsun Wai Chow, Qi-You Yu, Liang-Chuan Lai, Shi-Chuen Miaw
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Stabilization of Hypoxia-Inducible Factor Promotes Antimicrobial Activity of Human Macrophages Against Mycobacterium tuberculosis
    Sebastian F. Zenk, Sebastian Hauck, Daniel Mayer, Mark Grieshober, Steffen Stenger
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • BICD Cargo Adaptor 1 (BICD1) Downregulation Correlates with a Decreased Level of PD-L1 and Predicts a Favorable Prognosis in Patients with IDH1-Mutant Lower-Grade Gliomas
    Shang-Pen Huang, Chien-Hsiu Li, Wei-Min Chang, Yuan-Feng Lin
    Biology.2021; 10(8): 701.     CrossRef
  • The cytotoxic effect of Baeckea frustescens extracts in eliminating hypoxic breast cancer cells
    S. H. Shahruzaman, F. Z. Yusof, S. Maniam, S. Fakurazi, S. Maniam
    BMC Complementary Medicine and Therapies.2021;[Epub]     CrossRef
  • A highly annotated database of genes associated with platinum resistance in cancer
    Dongqing Huang, Sara R. Savage, Anna P. Calinawan, Chenwei Lin, Bing Zhang, Pei Wang, Timothy K. Starr, Michael J. Birrer, Amanda G. Paulovich
    Oncogene.2021; 40(46): 6395.     CrossRef
  • Lung Adenocarcinoma Transcriptomic Analysis Predicts Adenylate Kinase Signatures Contributing to Tumor Progression and Negative Patient Prognosis
    Jonathan A. Chacon-Barahona, Ivan A. Salladay-Perez, Nathan James Lanning
    Metabolites.2021; 11(12): 859.     CrossRef
  • Clinicopathological significance and angiogenic role of the constitutive phosphorylation of the FOXO1 transcription factor in colorectal cancer
    Young San Ko, Nae Yu Kim, Jung-Soo Pyo
    Pathology - Research and Practice.2020; 216(11): 153150.     CrossRef
  • Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
    Yue Zhao, Fei Feng, Qing-Hong Guo, Yu-Ping Wang, Rui Zhao
    World Journal of Gastroenterology.2020; 26(34): 5074.     CrossRef
  • Still Living Better through Chemistry: An Update on Caloric Restriction and Caloric Restriction Mimetics as Tools to Promote Health and Lifespan
    Carla Almendáriz-Palacios, Darrell D. Mousseau, Christopher H. Eskiw, Zoe E. Gillespie
    International Journal of Molecular Sciences.2020; 21(23): 9220.     CrossRef
  • Long Noncoding RNA Expression Profiling Reveals Upregulation of Uroplakin 1A and Uroplakin 1A Antisense RNA 1 under Hypoxic Conditions in Lung Cancer Cells
    Yuree Byun, Young-Chul Choi, Yongsu Jeong, Jaeseung Yoon, Kwanghee Baek
    Molecules and Cells.2020; 43(12): 975.     CrossRef
  • Convergent evolution on the hypoxia-inducible factor (HIF) pathway genes EGLN1 and EPAS1 in high-altitude ducks
    Allie M. Graham, Kevin G. McCracken
    Heredity.2019; 122(6): 819.     CrossRef
  • Inhibitory effects of plasmid small interfering RNA targeting signal transducer and activator of transcription‑3 in C6 glioma cells
    Jiajun Chen, Yue Zhou, Xiangyu Zhou, Jia Li, Feng Liu, Qingwei Zhou
    Molecular Medicine Reports.2019;[Epub]     CrossRef
  • Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review
    Dongqing Guo, Colin E. Murdoch, Tianhua Liu, Jia Qu, Shihong Jiao, Yong Wang, Wei Wang, Xing Chen
    Frontiers in Pharmacology.2018;[Epub]     CrossRef
  • ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications
    Danbi Lee, Myoung-Kuk Jang, Ji Hae Seo, Soo Hyung Ryu, Jeong A. Kim, Young-Hwa Chung
    Experimental & Molecular Medicine.2018; 50(7): 1.     CrossRef
  • Low dose radiation primed iNOS + M1macrophages modulate angiogenic programming of tumor derived endothelium
    Vinod Nadella, Sandhya Singh, Aklank Jain, Manju Jain, Karen M. Vasquez, Ashok Sharma, Pranay Tanwar, Goura Kishore Rath, Hridayesh Prakash
    Molecular Carcinogenesis.2018; 57(11): 1664.     CrossRef
  • HIF-1 as a Marker of Age-Related Diseases Associated with Tissue Hypoxia
    E. S. Popravka, N. S. Linkova, S. V. Trofimova, V. Kh. Khavinson
    Biology Bulletin Reviews.2018; 8(6): 497.     CrossRef
  • HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer
    Satoshi Sugita, Hideki Enokida, Hirofumi Yoshino, Kazutaka Miyamoto, Masaya Yonemori, Takashi Sakaguchi, Yoichi Osako, Masayuki Nakagawa
    International Journal of Oncology.2018;[Epub]     CrossRef
  • HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3
    Tao Han, Jun Yan, Haini Chen, Yi Ji, Jianbing Chen, Jie Cui, Weimin Shen, Jijun Zou
    International Journal of Oncology.2018;[Epub]     CrossRef
  • Silencing Ubc9 expression suppresses osteosarcoma tumorigenesis and enhances chemosensitivity to HSV-TK/GCV by regulating connexin�43 SUMOylation
    Dianying Zhang, Kai Yu, Zhong Yang, Yanxia Li, Xiaofang Ma, Xiyun Bian, Fengting Liu, Lili Li, Xiaozhi Liu, Wenhan Wu
    International Journal of Oncology.2018;[Epub]     CrossRef
  • BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation
    Prabhu Thirusangu, V. Vigneshwaran, T. Prashanth, B. R. Vijay Avin, Vikas H. Malojirao, H. Rakesh, Shaukath Ara Khanum, Riaz Mahmood, B. T. Prabhakar
    Angiogenesis.2017; 20(1): 55.     CrossRef
  • Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories
    Anthony R. Martin, Cyril Ronco, Luc Demange, Rachid Benhida
    MedChemComm.2017; 8(1): 21.     CrossRef
  • A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1α nuclear translocation and its target gene activation against neoplastic progression
    Prabhu Thirusangu, V. Vigneshwaran, V. Lakshmi Ranganatha, B.R. Vijay Avin, Shaukath Ara Khanum, Riaz Mahmood, K. Jayashree, B.T. Prabhakar
    Biochemical Pharmacology.2017; 125: 26.     CrossRef
  • Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling
    Ming Yue Li, Chunliu Mi, Ke Si Wang, Zhe Wang, Hong Xiang Zuo, Lian Xun Piao, Guang Hua Xu, Xuezheng Li, Juan Ma, Xuejun Jin
    Chemico-Biological Interactions.2017; 274: 58.     CrossRef
  • Nuclear translocation of HIF-1α induced by influenza A (H1N1) infection is critical to the production of proinflammatory cytokines
    Xinkun Guo, Zhaoqin Zhu, Wanju Zhang, Xiaoxiao Meng, Yong Zhu, Peng Han, Xiaohui Zhou, Yunwen Hu, Ruilan Wang
    Emerging Microbes & Infections.2017; 6(1): 1.     CrossRef
  • Hypoxia-inducible factor-1α in Antarctic notothenioids contains a polyglutamine and glutamic acid insert that varies in length with phylogeny
    A. S. Rix, T. J. Grove, K. M. O’Brien
    Polar Biology.2017; 40(12): 2537.     CrossRef
  • 125I seed irradiation induces apoptosis and inhibits angiogenesis by decreasing HIF-1α and VEGF expression in lung carcinoma xenografts
    Gui-Ling Xiang, Xin-Hong Zhu, Cun-Zhi Lin, Li-Jun Wang, Yong Sun, Yi-Wei Cao, Fang-Fang Wang
    Oncology Reports.2017; 37(5): 3075.     CrossRef
  • Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1
    Sue Youn Kim, Young San Ko, Jinju Park, Yiseul Choi, Jong-Wan Park, Younghoon Kim, Jung-Soo Pyo, Young Bok Yoo, Jae-Seon Lee, Byung Lan Lee
    Cancer Research and Treatment.2016; 48(1): 345.     CrossRef
  • Aryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in Breast Cancer Cells
    En-Yu Li, Wei-Yung Huang, Ya-Chu Chang, Mong-Hsun Tsai, Eric Y. Chuang, Qian-Yu Kuok, Shih-Ting Bai, Lo-Yun Chao, Yuh-Pyng Sher, Liang-Chuan Lai
    Scientific Reports.2016;[Epub]     CrossRef
  • Transcriptional regulation of human and murine short-chain dehydrogenase/reductases (SDRs) – an in silico approach
    Bettina Ebert, Michael Kisiela, Edmund Maser
    Drug Metabolism Reviews.2016; 48(2): 183.     CrossRef
  • Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma
    Mingxiao Lang, Xiuchao Wang, Hongwei Wang, Jie Dong, Chungen Lan, Jihui Hao, Chongbiao Huang, Xin Li, Ming Yu, Yanhui Yang, Shengyu Yang, He Ren
    Cancer Letters.2016; 378(2): 87.     CrossRef
  • Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein–Coupled Receptor OGR1 (GPR68)
    Cheryl de Vallière, Jesus Cosin-Roger, Simona Simmen, Kirstin Atrott, Hassan Melhem, Jonas Zeitz, Mehdi Madanchi, Irina Tcymbarevich, Michael Fried, Gerd A. Kullak-Ublick, Stephan R. Vavricka, Benjamin Misselwitz, Klaus Seuwen, Carsten A. Wagner, Jyrki J.
    Cellular and Molecular Gastroenterology and Hepatology.2016; 2(6): 796.     CrossRef
  • Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models
    J. P. Phelan, F. J. Reen, N. Dunphy, R. O’Connor, F. O’Gara
    BMC Cancer.2016;[Epub]     CrossRef
  • Better Living through Chemistry: Caloric Restriction (CR) and CR Mimetics Alter Genome Function to Promote Increased Health and Lifespan
    Zoe E. Gillespie, Joshua Pickering, Christopher H. Eskiw
    Frontiers in Genetics.2016;[Epub]     CrossRef
  • Folic Acid Represses Hypoxia-Induced Inflammation in THP-1 Cells through Inhibition of the PI3K/Akt/HIF-1α Pathway
    Xiaoyan Huang, Zhiying He, Xinwei Jiang, Mengjun Hou, Zhihong Tang, Xiaozhou Zhen, Yuming Liang, Jing Ma, George Simos
    PLOS ONE.2016; 11(3): e0151553.     CrossRef
  • Cinnamic aldehyde suppresses hypoxia-induced angiogenesis via inhibition of hypoxia-inducible factor-1α expression during tumor progression
    Woom-Yee Bae, Jae-Sun Choi, Ja-Eun Kim, Joo-Won Jeong
    Biochemical Pharmacology.2015; 98(1): 41.     CrossRef
  • Clinicopathological Significance of MicroRNA-20b Expression in Hepatocellular Carcinoma and Regulation of HIF-1αand VEGF Effect on Cell Biological Behaviour
    Tong-min Xue, Li-de Tao, Miao Zhang, Jie Zhang, Xia Liu, Guo-feng Chen, Yi-jia Zhu, Pei-Jian Zhang
    Disease Markers.2015; 2015: 1.     CrossRef
  • HIF-1α Contributes to Proliferation and Invasiveness of Neuroblastoma Cells via SHH Signaling
    Sheng Chen, Min Zhang, Lili Xing, Yue Wang, Yongtao Xiao, Yeming Wu, Sharmila Shankar
    PLOS ONE.2015; 10(3): e0121115.     CrossRef
  • Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis
    JI HAE SEO, JI-HYEON PARK, EUN JI LEE, TAM THUY LU VO, HOON CHOI, JAE KYUNG JANG, HEE-JUN WEE, BUM JU AHN, JONG-HO CHA, MIN WOOK SHIN, KYU-WON KIM
    International Journal of Oncology.2015; 46(1): 99.     CrossRef
  • Transcriptome sequencing revealed differences in the response of renal cancer cells to hypoxia and CoCl2 treatment
    Nadezhda Zhigalova, Artem Artemov, Alexander M. Mazur, Egor B. Prokhortchouk
    F1000Research.2015; 4: 1518.     CrossRef
  • The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
    Dongjun Luo, Zhongxia Wang, Junyi Wu, Chunping Jiang, Junhua Wu
    BioMed Research International.2014; 2014: 1.     CrossRef
  • Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer
    Kelie M Reece, Emily D Richardson, Kristina M Cook, Tessa J Campbell, Stephen T Pisle, Alesia J Holly, David J Venzon, David J Liewehr, Cindy H Chau, Douglas K Price, William D Figg
    Molecular Cancer.2014;[Epub]     CrossRef
  • Exploring the Modulation of Hypoxia-Inducible Factor (HIF)-1α by Volatile Anesthetics as a Possible Mechanism Underlying Volatile Anesthetic-Induced CNS Injury
    Emma K. Giles, Andrew J. Lawrence, Jhodie R. Duncan
    Neurochemical Research.2014; 39(9): 1640.     CrossRef
  • Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus
    H Fan, F Liu, G Dong, D Ren, Y Xu, J Dou, T Wang, L Sun, Y Hou
    Cell Death & Disease.2014; 5(9): e1416.     CrossRef
  • Sleep apnoea and cancer: the new challenge
    Patrick Lévy, Diane Godin-Ribuot, Jean-Louis Pepin
    European Respiratory Journal.2014; 43(6): 1567.     CrossRef
  • [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer
    Ryusuke Takebayashi, Kunihiko Izuishi, Yuka Yamamoto, Reiko Kameyama, Hirohito Mori, Tsutomu Masaki, Yasuyuki Suzuki
    Journal of Experimental & Clinical Cancer Research.2013;[Epub]     CrossRef
  • The influence of pH and hypoxia on tumor metastasis
    Mariam Abaza, Yunus A Luqmani
    Expert Review of Anticancer Therapy.2013; 13(10): 1229.     CrossRef
  • Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
    Yan Xia, Hyun-Kyung Choi, Kyeong Lee
    European Journal of Medicinal Chemistry.2012; 49: 24.     CrossRef
  • Molecular Mechanism Underlying the Detection of Colorectal Cancer by 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography
    Kunihiko Izuishi, Yuka Yamamoto, Takanori Sano, Ryusuke Takebayashi, Yoshihiro Nishiyama, Hirohito Mori, Tsutomu Masaki, Asahiro Morishita, Yasuyuki Suzuki
    Journal of Gastrointestinal Surgery.2012; 16(2): 394.     CrossRef
  • A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis
    S Y Nam, Y S Ko, J Jung, J Yoon, Y H Kim, Y J Choi, J W Park, M S Chang, W H Kim, B L Lee
    British Journal of Cancer.2011; 104(1): 166.     CrossRef
  • Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules
    Sue Youn Kim, Jiyeon Yoon, Young San Ko, Mee Soo Chang, Jong-Wan Park, Hee Eun Lee, Min A Kim, Ji Hun Kim, Woo Ho Kim, Byung Lan Lee
    BMC Cancer.2011;[Epub]     CrossRef
  • Terpestacin Inhibits Tumor Angiogenesis by Targeting UQCRB of Mitochondrial Complex III and Suppressing Hypoxia-induced Reactive Oxygen Species Production and Cellular Oxygen Sensing
    Hye Jin Jung, Joong Sup Shim, Jiyong Lee, Young Mi Song, Ki Chung Park, Seung Hoon Choi, Nam Doo Kim, Jeong Hyeok Yoon, Paul T. Mungai, Paul T. Schumacker, Ho Jeong Kwon
    Journal of Biological Chemistry.2010; 285(15): 11584.     CrossRef
  • The Clinicopathological Significance of Tissue Levels of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor in Gastric Cancer
    Seong-Eun Kim, Ki-Nam Shim, Sung-Ae Jung, Kwon Yoo, Joo Ho Lee
    Gut and Liver.2009; 3(2): 88.     CrossRef
  • 29,963 View
  • 622 Download
  • 77 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP